Sankala Group’s Cardinal Health CAH Stock Holding History

Sankala Group’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2K	Hold	5	–	–	﹤0.01%	541
2026 Q1	$1.05K	Hold	5	–	–	﹤0.01%	525
2025 Q4	$1.17K	Buy	+5	New	+$941	﹤0.01%	530

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Sankala Group's CAH Position: Q2 2026 in Review

Sankala Group held its Cardinal Health (CAH) position steady in Q2 2026 at 5 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #541.

Sankala Group first reported a position in CAH in Q4 2025 and has held it in 3 quarters since. 1,501 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Sankala Group held 5 shares of Cardinal Health worth $1.2K as of Q2 2026.
Sankala Group left its Cardinal Health share count unchanged in Q2 2026.
Cardinal Health made up ﹤0.01% of Sankala Group's portfolio in Q2 2026, its #541 holding.
Sankala Group first reported a position in Cardinal Health in Q4 2025 and has held it in 3 quarters since.
1,501 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Sankala Group's 13F filing for Q2 2026, filed 18 Aug 2026.